Nanjing Well Pharmaceutical Group Co.,Ltd. (SHA:603351)

Market Cap	4.02B
Revenue (ttm)	1.32B
Net Income (ttm)	148.41M
Shares Out	135.44M
EPS (ttm)	1.09
PE Ratio	27.51
Forward PE	n/a
Dividend	0.40 (1.41%)
Ex-Dividend Date	Jun 13, 2024

Volume	7,928,472
Average Volume	3,547,128
Open	28.46
Previous Close	28.46
Day's Range	27.77 - 30.26
52-Week Range	18.81 - 31.88
Beta	0.37
RSI	70.32
Earnings Date	Apr 22, 2025

About SHA:603351

Nanjing Well Pharmaceutical Group Co.,Ltd. focuses on the research and development, production, and sale of pharmaceutical auxiliary materials in China. Its pharmaceutical materials include excipients for injectables and non-injectables. The company also provides synthetic base oils, such as hydraulic fluids, lubricity additives for metals, metal quenching, base fluids and lubricity additives, synthetic base for compress lubricants, synthetic base oil for gear, base oil of chain lubricants, base stock of engine oil, base stock of heat transfer ...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 2000
• Employees: 673
• Stock Exchange: Shanghai Stock Exchange
• Ticker Symbol: 603351

Financial Performance

In 2024, SHA:603351's revenue was 1.30 billion, an increase of 12.19% compared to the previous year's 1.16 billion. Earnings were 146.42 million, an increase of 30.50%.